Plain-English translation of NCT05501379 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Lymphoma research guide →Doctors know that staying physically active during cancer treatment can help with treatment outcomes, but they're not sure which method works best to measure activity in cancer patients. This study compares two approaches: wearing a small motion tracker (accelerometer) and answering a questionnaire about your daily activity. The research team will use both methods at different points during your cancer treatment to see which one gives the most accurate picture of how active you are.
Physical activity is important for cancer patients, but doctors need to know the best way to measure it accurately so they can understand whether activity levels affect how well treatment works.
You likely qualify if…
You likely don't qualify if…
You will wear a small motion tracker device (accelerometer) at different times during your cancer treatment to record your daily physical activity. You will also complete a questionnaire asking about your activity levels. The study will collect this information at multiple time points throughout your treatment, allowing researchers to compare what the motion tracker records versus what you report in the questionnaire.
AI-generated summary from trial data · Jun 9, 2026 · Not medical advice
Germany
Enrollment target
~60 participants
Started
September 2022
Primary completion
December 2024
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
18 Years and older
Last updated on clinicaltrials.gov in December 2024.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Ali A Aghdassi, Professor
University Medicine Greifswald
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.